Clinical evidence further substantiates these findings, demonstrating an increased proportion of liver and circulating Th1 cells producing IFN-γ in both pediatric and adult patients with MASH (123, 124). The gene discussed is IFNG; the disease is metabolic dysfunction-associated steatohepatitis.